Factor V Leiden: should all women be screened prior to commencing the contraceptive pill? (Q33606504)

28 July 2017

1 reference

title

Factor V Leiden: should all women be screened prior to commencing the contraceptive pill? (English)

1 reference

28 July 2017

1 reference

Walker ID

1

1 reference

28 July 2017

language of work or name

1 reference

1 March 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

13

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

8-13

1 reference

Mutation in blood coagulation factor V associated with resistance to activated protein C.

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Absence of thrombosis in subjects with heterozygous protein C deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Prevalence of antithrombin deficiency in the healthy population.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Third-generation oral contraceptive and deep venous thrombosis: from epidemiologic controversy to new insight in coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Resistance to activated protein C in healthy women taking oral contraceptives.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Factor V Leiden: should we screen oral contraceptive users and pregnant women?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

The natural history and epidemiology of venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

The family history and inherited thrombophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2899%2990019-X

7 January 2021

10.1016/S0268-960X(99)90019-X

Identifiers

DOI

1 reference

28 July 2017

1 reference